Drug Discovery, Design, and Development

Drug Discovery, Design, and Development encompass a multi-disciplinary approach integrating cutting-edge technologies, bioinformatics, and molecular modeling to identify novel therapeutic agents. This process spans target identification, hit-to-lead optimization, preclinical testing, and clinical trials. Advances in computational drug design, high-throughput screening, and biomarker discovery are revolutionizing the field, enabling precision medicine and accelerating time-to-market for new treatments. By leveraging systems biology, cheminformatics, and AI-driven methodologies, researchers are uncovering innovative strategies to combat complex diseases, including cancer, neurodegenerative disorders, and metabolic diseases. This conference will foster collaboration, driving forward the future of drug innovation and therapeutic development.

    Related Conference of Drug Discovery, Design, and Development

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Drug Discovery, Design, and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in